COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,184 Articles (22,713 medRxiv, 8,471 bioRxiv)

Most recent first Previous |  Page 331: Articles 3301-3310  | Next

Impact of bivalent BA.4/5 BNT162b2 COVID-19 vaccine on acute symptoms, quality of life, work productivity and activity levels among symptomatic US adults testing positive for SARS-CoV-2 at a national retail pharmacy
Di Fusco, M., Sun, X., Anatale-Tardiff, L., Yehoshua, A., Coetzer, H., Alvarez, M. B., Allen, K. E., Porter, T. M., Puzniak, L., Lopez, S. M. C., Cappelleri, J. C.
10.1101/2023.09.21.23295904 — Posted: 2023-09-23
Group A streptococcal cases and treatments during the COVID-19 pandemic and 2022 outbreak: a retrospective cohort study in England using OpenSAFELY-TPP
Cunningham, C., Fisher, L., Wood, C., The OpenSAFELY Collaborative, , Speed, V., Brown, A. D., Curtis, H. J., Higgins, R., Croker, R., Butler-Cole, B. F., Evans, D., Inglesby, P., Dillingham, I., Bacon, S. C., Beech, E., Hand, K., Davy, S., Ward, T., Hickman, G., Bridges, L., O'Dwyer, T., Maude, S., Smith, R. M., Mehrkar, A., Hart, L. C., Bates, C., Cockburn, J., Parry, J., Hester, F., Goldacre, B., MacKenna, B.
10.1101/2023.09.22.23295850 — Posted: 2023-09-23
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021 to June 2022
Sumner, K. M., Yadav, R., Noble, E. K., Sandford, R., Joshi, D. J., Tartof, S. Y., Wernli, K. J., Martin, E. T., Gaglani, M., Zimmerman, R., Talbot, H. K., Grijalva, C. G., Chung, J., Flannery, B. M., Coughlin, M. M., Rogier, E.
10.1101/2023.09.21.23295919 — Posted: 2023-09-23
Liver abnormalities following SARS-CoV-2 infection in children under 10 years of age
Terebuh, P., Olaker, V. R., Kendall, E. K., Kaelber, D. C., Xu, R., Davis, P. B.
10.1101/2023.09.21.23295905 — Posted: 2023-09-23
Simulation-based validation of a method to detect changes in SARS-CoV-2 reinfection risk
Lombard, B., Moultrie, H., Pulliam, J. R., Van Schalkwyk, C.
10.1101/2023.09.21.23295891 — Posted: 2023-09-23
Targeted MRM-analysis of plasma proteins in frozen whole blood samples from patients with COVID-19
Bugrova, A. E., Strelnikova, P. A., Kononikhin, A. S., Zakharova, N. V., Diyachkova, E. O., Brzhozovskiy, A. G., Indeykina, M. I., Kurochkin, I. N., Averyanov, A. V., Nikolaev, E. N.
10.1101/2023.09.20.23295832 — Posted: 2023-09-22
Statistical analysis of three data sources for Covid-19 monitoring in Rhineland-Palatinate, Germany
Pilz, M., Kuefer, K.-H., Mohring, J., Muench, J., Wlazlo, J., Leithaeuser, N.
10.1101/2023.09.21.23295894 — Posted: 2023-09-22
Enhancing social inclusion through the implementation of evidence-based digital health interventions for mental health and alcohol other drug use problems in the wake of COVID-19: A study protocol
Kay-Lambkin, F., Rich, J. L., Sampson, D., Thornton, L., Heinsch, M., Filia, K., Kelly, B., Weiss, A., Wright, M., Simmonette, D., Teeson, M.
10.1101/2023.09.20.23295867 — Posted: 2023-09-22
TMPRSS2 activation of Omicron lineage Spike glycoproteins is regulated by TMPRSS2 cleavage of ACE2
Aggarwal, A., Fichter, C., Milogiannakis, V., Akerman, A., Ison, T., Ruiz Silva, M., Esneau, C., Bartlett, N., Burrell, L., Patel, S., Churchill, M., Angelovich, T., Parry, R., Sng, J. D., Neely, G. G., Moreno, C. L., Loo, L., Kelleher, A. D., Brilot, F., Khromykh, A., Turville, S. G.
10.1101/2023.09.22.558930 — Posted: 2023-09-22
COVID-19 VACCINE ACCEPTANCE AND HESITANCY IN GHANA: A SYSTEMATIC REVIEW
Akrong, G. B., Hiadzi, R. A., Donkor, A. B., Anafo, D. K.
10.1101/2023.09.19.23295768 — Posted: 2023-09-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).